Analyzing X Mentions, how is Akebia Therapeutics performing compared to its industry peers?

Akebia Therapeutics underperforms its industry peers when it comes to X Mentions, ranking in the 1st percentile.

Why should an investor track X mentions?

Investors should track mentions of Akebia Therapeutics on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.

Akebia Therapeutics (AKBA) X Mentions Statistics 2025

Company	X Mentions
	Amgen AMGN	30 11.1%
	Gilead Sciences GILD	25 92.3%
	Catalyst Pharmaceuticals CPRX	12
	Inovio Pharmaceuticals INO	12 20%
	Anavex Life Sciences AVXL	9 40%

Company

X Mentions

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

Top Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
House & Congress Trading
Earnings Calendar
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Akebia Therapeutics (AKBA) - X Mentions

Similar companies

Amgen

Gilead Sciences

Catalyst Pharmaceuticals

Inovio Pharmaceuticals

Anavex Life Sciences

Analyzing X Mentions, how is Akebia Therapeutics performing compared to its industry peers?

Why should an investor track X mentions?

Chat with AltIndex AI